MetaCap

Eikon Therapeutics Statistics

NASDAQ: EIKNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

4.74-0.02 (-0.42%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Eikon Therapeutics by the numbers

Eikon Therapeutics has a market capitalization of $256.8 million based on 54.19M shares outstanding. With trailing EPS of $-7.86, Eikon Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 32.5% below its 50-day average and 52.8% below its 200-day average.

Average daily trading volume is 560.40K shares, or about $2.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EIKN valuation vs. peer median

EIKN compared with the median of 8 peer companies
MetricEIKNPeer medianDifference
Market cap$256.84M$256.85M-0%
Avg. volume560.40K904.32K-38%

Peer median across 8 companies: OCGN, SABS, EDIT, AGMB, KYTX, AGEN, LXEO, PLX.

Valuation

Price and trading

Previous close
4.76
Open
4.85
Day range
4.74 – 5.19
52-week range
4.72 – 17.40
Beta
—
Volume
691.44K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
256.84M
Forward Pe
-0.74
Eps
-7.86
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.40
Week52 Low
4.72
Avg Volume
560.40K
Shares Outstanding
54.19M
Ma50
7.02
Ma200
10.05
Earnings Date
Nov 12, 2026
Pct From52w High
-72.76%
Pct From52w Low
0.42%

Related